Independent advisory for Lab Automation and High-Content Imaging
CELLIMA helps pharma, biotech, and research teams validate infrastructure and workflow decisions before procurement or rollout.
Vendor-neutral. Scientifically grounded. Based on 20+ years in pharmaceutical R&D.
No pitch. We clarify whether CELLIMA can help — and what the right next step would be.
When CELLIMA Fits
Before procuring imaging and lab automation infrastructure
When setting up or restructuring a Core Facility
When scaling image-based or automated workflows in Discovery
Advisory Engagements
Workflow Diagnostic
Structured assessment of an existing or planned imaging or automation setup.
Written decision brief with prioritized options.
Architecture
Target architecture for imaging or automation infrastructure prior to procurement.
Reference architecture document + vendor-neutral specification.
Pilot Workflow
Design and supervision of a pilot workflow before full rollout.
Validated SOP + go/no-go recommendation.
Optimization
Targeted review of operational systems with bottlenecks or scaling issues.
Structured audit report + prioritized intervention plan.
Track Record
"Stefan brought both scientific depth and structural clarity into our imaging setup."Andrea Faedo Head of Molecular and Cellular Biology Group
"Stefan's expertise in evaluating high-content imaging approaches has been instrumental in advancing our drug discovery projects."Anke Müller-Fahrnow VP, Senior Advisor Innovation Campus Berlin
Selected organizations from consulting engagements and scientific collaborations.
BAYER
NUVISAN
AXXAM
ABBERIOR
NGNRI
BROAD
DZNE
Core Life Analytics
KOLAIDO
BAYER NUVISAN AXXAM ABBERIOR NGNRI BROAD DZNE Core Life Analytics KOLAIDO